CaltechAUTHORS
Published September 13, 2006 | Version Supplemental Material + Accepted Version
Journal Article Open

A Convergent and Enantioselective Synthesis of (+)-Amurensinine via Selective C−H and C−C Bond Insertion Reactions

Creators

  • 1. ROR icon California Institute of Technology

Abstract

A convergent and enantioselective synthesis of the natural product amurensinine is described. The synthetic strategy takes advantage of mild and selective C−H and C−C bond insertion reactions, in addition to the palladium-catalyzed aerobic oxidative kinetic resolution recently developed in these laboratories.

Additional Information

© 2006 American Chemical Society. Received 20 July 2006. Published online 17 August 2006. Published in print 1 September 2006. The authors are grateful to the NIH-NIGMS (R01 GM65961-01), NDSEG (predoctoral fellowships to U.K.T. and D.C.E.), NSF (predoctoral fellowship to D.C.E.), A. P. Sloan Foundation, Research Corporation, Bristol-Myers Squibb, Amgen, Merck, Pfizer, Novartis, Lilly, Roche, Abbott, AstraZeneca, and Caltech for financial support.

Attached Files

Accepted Version - nihms-63703.pdf

Supplemental Material - ja0651815si20060804_084023.pdf

Files

ja0651815si20060804_084023.pdf

Files (1.7 MB)

Name Size
md5:1e0b910c85b41640c1ff6ad9a19b68be
1.4 MB Preview Download
md5:51e1e85b7f7fe18d08d6f8ca81c40f4b
295.6 kB Preview Download

Additional details

Identifiers

PMCID
PMC2529249
Eprint ID
74438
Resolver ID
CaltechAUTHORS:20170221-152140812

Funding

NIH
R01GM65961-01
National Defense Science and Engineering Graduate (NDSEG) Fellowship
NSF Predoctoral Fellowship
Alfred P. Sloan Foundation
Research Corporation
Bristol-Myers Squibb
Amgen
Merck
Pfizer
Novartis
Lilly
Roche
Abbott
AstraZeneca
Caltech

Dates

Created
2017-02-22
Created from EPrint's datestamp field
Updated
2021-11-11
Created from EPrint's last_modified field